STEMI standing orders

In STEMI patients undergoing PCI who are at high risk of bleeding, bivalirudin anticoagulation is reasonable (Class IIa, LOE: B).b For prior treatment with fondaparinux, administer additional intravenous treatment with an anticoagulant possessing anti-IIa activity (such as UFH or bivalirudin), taking into account whether GP IIb/IIIa inhibitors ... ................
................